<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Gender plays a pivotal role in the <z:hpo ids='HP_0003674'>onset</z:hpo> as well as in the progression of the <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> with a higher morbidity and mortality being detected in men with respect to women </plain></SENT>
<SENT sid="1" pm="."><plain>Type 2 <z:hpo ids='HP_0000819'>Diabetes Mellitus</z:hpo> (T2DM) may reduce gender-related differences in the prevalence of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> by fading the vascular protective effects afforded by <z:chebi fb="0" ids="50114">estrogen</z:chebi> in females </plain></SENT>
<SENT sid="2" pm="."><plain>This article will discuss the role of sex and sex hormones on the incidence and mechanisms involved in vascular dysfunction associated to T2DM, which might explain why women with T2DM lack the vascular protection </plain></SENT>
</text></document>